Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
18 févr. 2021 17h24 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on...
Harvard Bioscience Announces New Credit Facility
22 déc. 2020 18h05 HE
|
Harvard Bioscience, Inc.
Improves liquidity and operating flexibilitySignificantly reduces borrowing costsSupports ongoing transformation to profitable growth platform HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) --...
Harvard Bioscience to attend Benchmark’s 9th Annual Discovery One-on-One Conference
16 nov. 2020 16h35 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in...
Harvard Bioscience Announces Third Quarter 2020 Financial Results
05 nov. 2020 07h00 HE
|
Harvard Bioscience, Inc.
Operating margin up year-over-year on GAAP and adjusted basisRevenue improved sequentially with solid CRO/pharma demand and academic labs reopeningGenerated positive operating cash flow in Q3 with...
Harvard Bioscience Schedules Third Quarter 2020 Earnings Conference Call for November 5, 2020 at 8:00 AM ET
20 oct. 2020 16h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, MA., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on...
Harvard Bioscience to Present at Singular Research Compelling Values Webinar
16 sept. 2020 16h30 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, President and CEO, will present at the Singular Research Compelling...
Harvard Bioscience Announces Second Quarter 2020 Financial Results
05 août 2020 07h00 HE
|
Harvard Bioscience, Inc.
Operating Income up sequentially and year-over-year on both GAAP and adjusted basisCost reduction programs offset expected declines in Academic marketsNet Debt reduced by $2.2 million in Q2 ...
Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
20 juil. 2020 08h30 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2020 before the market opens on...
Harvard Bioscience, Inc. Issues Letter to Shareholders
26 mai 2020 17h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Jim Green, Chairman, President & Chief Executive Officer of Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”),...
Harvard Bioscience Announces First Quarter 2020 Financial Results
05 mai 2020 07h00 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three months ended March 31, 2020. The Company...